Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.

2.50
Hdl Handle:
http://hdl.handle.net/10029/621950
Title:
Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.
Authors:
Jonker, Emile F F; van Ravenhorst, Mariëtte B; Berbers, Guy A M; Visser, Leo G
Abstract:
Vaccination with conjugated meningococcal vaccines is the best way to prevent invasive meningococcal disease. Changes in serogroup epidemiology have led to the inclusion of quadrivalent vaccines in the national immunization programs of several countries, but vaccines are frequently in short supply. Intradermal administration has the potential to increase vaccine availability through dose reduction, without sacrificing efficacy. It has never before been investigated for glycoconjugate meningococcal vaccines.
Citation:
Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines. 2018 Vaccine
Journal:
Vaccine 2018; advance online publication (ahead of print)
Issue Date:
16-May-2018
URI:
http://hdl.handle.net/10029/621950
DOI:
10.1016/j.vaccine.2018.05.064
PubMed ID:
29778515
Type:
Article
Language:
en
ISSN:
1873-2518
Appears in Collections:
Miscellaneous

Full metadata record

DC FieldValue Language
dc.contributor.authorJonker, Emile F Fen
dc.contributor.authorvan Ravenhorst, Mariëtte Ben
dc.contributor.authorBerbers, Guy A Men
dc.contributor.authorVisser, Leo Gen
dc.date.accessioned2018-05-27T13:00:59Z-
dc.date.available2018-05-27T13:00:59Z-
dc.date.issued2018-05-16-
dc.identifier.citationSafety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines. 2018 Vaccineen
dc.identifier.issn1873-2518-
dc.identifier.pmid29778515-
dc.identifier.doi10.1016/j.vaccine.2018.05.064-
dc.identifier.urihttp://hdl.handle.net/10029/621950-
dc.description.abstractVaccination with conjugated meningococcal vaccines is the best way to prevent invasive meningococcal disease. Changes in serogroup epidemiology have led to the inclusion of quadrivalent vaccines in the national immunization programs of several countries, but vaccines are frequently in short supply. Intradermal administration has the potential to increase vaccine availability through dose reduction, without sacrificing efficacy. It has never before been investigated for glycoconjugate meningococcal vaccines.en
dc.language.isoenen
dc.rightsinfo:eu-repo/semantics/closedAccessen
dc.titleSafety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.en
dc.typeArticleen
dc.identifier.journalVaccine 2018; advance online publication (ahead of print)en

Related articles on PubMed

All Items in WARP are protected by copyright, with all rights reserved, unless otherwise indicated.